Drugs / IDP-107
last change Dec 2011 re-read 3 minutes ago

IDP-107

Developed for
acne
Investigated by
Dow Pharmaceutical Sciences

Trials 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01194375 Sep 2010 → Dec 2011 acne Dow Pharmaceutical Sciences Completed No outcome recorded
Phase 2 NCT00666900 Jan 2008 → Mar 2009 acne Dow Pharmaceutical Sciences Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as IDP-107 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01194375 ↗
1

NCT00666900 ↗